Epigral Ltd (EPIGRAL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,146.05",
    "chg": 14.35,
    "chgp": "1.27%",
    "dir": 1,
    "prev_price": "1,131.70",
    "mcapval": "4,856.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE071N01016",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "27.14 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/epigral-1003523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-3987263",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_mojoScore_3987263.png",
        "date": "2026-05-12 10:11:08",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd’s Mixed Week: -0.09% Price Change Amid Valuation Shifts and Financial Strains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltds-mixed-week--009-price-change-amid-valuation-shifts-and-financial-strains-3983032",
        "imagepath": "",
        "date": "2026-05-09 11:05:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Intraday high surge to Rs.1,378 (+15.35%)</p>\n                    <p><strong>4 May:</strong> Mixed quarterly results with record sales but declining PAT</p>\n                    <p><strong>5 May:</strong> Valuation metrics improve, signalling attractive price levels</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.1,327.55 (-0.09%) vs Sensex +1.25%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,328.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value..."
      },
      {
        "title": "Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-specialty-chemicals-sector-3974691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_valuationdot_3974691.png",
        "date": "2026-05-05 08:01:37",
        "description": "Epigral Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a recalibration of price attractiveness within the specialty chemicals sector. This change comes amid a strong price rally and improved relative valuation metrics compared to its peers, signalling potential opportunities for investors despite a cautious overall market stance."
      },
      {
        "title": "Epigral Ltd Reports Mixed Quarterly Results Amid Shifting Financial Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-reports-mixed-quarterly-results-amid-shifting-financial-trends-3974112",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_fintrenddot_3974112.png",
        "date": "2026-05-04 13:00:05",
        "description": "Epigral Ltd, a specialty chemicals company, has reported a mixed set of financial results for the quarter ended March 2026, reflecting a shift from a previously flat to a negative financial trend. While net sales and profit before tax have shown encouraging growth, key profitability metrics and operational ratios have deteriorated, signalling challenges ahead for this small-cap stock."
      },
      {
        "title": "When is the next results date for Epigral Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-epigral-ltd-3967242",
        "imagepath": "",
        "date": "2026-04-28 23:16:35",
        "description": "The next results date for Epigral Ltd is scheduled for 02 May 2026...."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-3953800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EpigralLtd_mojoScore_3953800.png",
        "date": "2026-04-20 10:10:48",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Epigral Ltd Surges 22.26% in a Week: Key Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-surges-2226-in-a-week-key-drivers-behind-the-rally-3942564",
        "imagepath": "",
        "date": "2026-04-11 11:03:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.900.25</p>\n                    <p><strong>7 Apr:</strong> Stock gains 5.62%, closing at Rs.950.80</p>\n                    <p><strong>8 Apr:</strong> Intraday high of Rs.1,022.60 with 7.28% gain</p>\n                    <p><strong>9 Apr:</strong> Modest 0.97% rise to Rs.1,020.90</p>\n                    <p><strong>10 Apr:</strong> Intraday high of Rs.1,084.75, closing at Rs.1,100.65 (+7.81%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.900.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">W..."
      },
      {
        "title": "Epigral Ltd Surges 7.36% to Day's High of Rs 1084.75 — Outperforms Sector by 5.06 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-hits-intraday-high-with-736-surge-on-10-apr-2026-3941886",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EpigralLtd_priceRelatedfactors_3941886.png",
        "date": "2026-04-10 15:16:00",
        "description": "The Sensex climbed 1.23% on 10 Apr 2026, yet Epigral Ltd outpaced the broader market with a 7.36% gain, touching an intraday high of Rs 1084.75. This 5.06 percentage-point outperformance over its Specialty Chemicals sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-3939375",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EpigralLtd_mojoScore_3939375.png",
        "date": "2026-04-09 10:10:32",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 15,
    "sid": "1003523",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/epigral-1003523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "10-Jun-2026",
      "details": "Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on June 16 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "09-Jun-2026",
      "details": "Submission of Scrutinizers Report of 19th AGM held on 08.06.2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "08-Jun-2026",
      "details": "Proceedings of 19th AGM held on 08.06.2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>50%</strong> dividend, ex-date: 01 Jun 26",
          "dt": "2026-06-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Epigral Ltd is Rated Sell by MarketsMOJO

2026-05-12 10:11:08

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.

Epigral Ltd’s Mixed Week: -0.09% Price Change Amid Valuation Shifts and Financial Strains

2026-05-09 11:05:59

Key Events This Week 4 May: Intraday high surge to Rs.1,378 (+15.35%) 4 May: Mixed quarterly results with record sales but declining PAT 5 May: Valuation metrics improve, signalling attractive price levels 8 May: Week closes at Rs.1,327.55 (-0.09%) vs Sensex +1.25% Week OpenRs.1,328.80 Week Close<div class="stat-value...

Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector

2026-05-05 08:01:37

Epigral Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a recalibration of price attractiveness within the specialty chemicals sector. This change comes amid a strong price rally and improved relative valuation metrics compared to its peers, signalling potential opportunities for investors despite a cautious overall market stance.

Epigral Ltd Reports Mixed Quarterly Results Amid Shifting Financial Trends

2026-05-04 13:00:05

Epigral Ltd, a specialty chemicals company, has reported a mixed set of financial results for the quarter ended March 2026, reflecting a shift from a previously flat to a negative financial trend. While net sales and profit before tax have shown encouraging growth, key profitability metrics and operational ratios have deteriorated, signalling challenges ahead for this small-cap stock.

When is the next results date for Epigral Ltd?

2026-04-28 23:16:35

The next results date for Epigral Ltd is scheduled for 02 May 2026....

Epigral Ltd is Rated Sell by MarketsMOJO

2026-04-20 10:10:48

Epigral Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date view of the company's performance and outlook.

Epigral Ltd Surges 22.26% in a Week: Key Drivers Behind the Rally

2026-04-11 11:03:36

Key Events This Week 6 Apr: Week opens at Rs.900.25 7 Apr: Stock gains 5.62%, closing at Rs.950.80 8 Apr: Intraday high of Rs.1,022.60 with 7.28% gain 9 Apr: Modest 0.97% rise to Rs.1,020.90 10 Apr: Intraday high of Rs.1,084.75, closing at Rs.1,100.65 (+7.81%) Week OpenRs.900.25 W...

Epigral Ltd Surges 7.36% to Day's High of Rs 1084.75 — Outperforms Sector by 5.06 Percentage Points

2026-04-10 15:16:00

The Sensex climbed 1.23% on 10 Apr 2026, yet Epigral Ltd outpaced the broader market with a 7.36% gain, touching an intraday high of Rs 1084.75. This 5.06 percentage-point outperformance over its Specialty Chemicals sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Epigral Ltd is Rated Sell

2026-04-09 10:10:32

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

View All News